MAPs for PrEP: Dissolving Microarray Patches (MAPs) for Long-acting HIV and Pregnancy Prevention

PATH and its partners are in the early stages of developing microarray patches (MAPs) containing cabotegravir for HIV pre-exposure prophylaxis (PrEP), as well as a MAP containing cabotegravir and a contraceptive—a multipurpose protection technology (MPT).

Corporate author(s): PATH

Publication date: February 2018

MAPs for PrEP: Dissolving Microarray Patches (MAPs) for Long-acting HIV and Pregnancy Prevention

516.7 KB PDF

Hard copies are available.
View Resource